Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Joyce M Richey"'
Autor:
Orison O Woolcott, Joyce M Richey, Morvarid Kabir, Robert H Chow, Malini S Iyer, Erlinda L Kirkman, Darko Stefanovski, Maya Lottati, Stella P Kim, L Nicole Harrison, Viorica Ionut, Dan Zheng, Isabel R Hsu, Karyn J Catalano, Jenny D Chiu, Heather Bradshaw, Qiang Wu, Cathryn M Kolka, Richard N Bergman
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0131033 (2015)
Externí odkaz:
https://doaj.org/article/acd325e4dfb44e77824615af03a18330
Autor:
Orison O Woolcott, Joyce M Richey, Morvarid Kabir, Robert H Chow, Malini S Iyer, Erlinda L Kirkman, Darko Stefanovski, Maya Lottati, Stella P Kim, L Nicole Harrison, Viorica Ionut, Dan Zheng, Isabel R Hsu, Karyn J Catalano, Jenny D Chiu, Heather Bradshaw, Qiang Wu, Cathryn M Kolka, Richard N Bergman
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123558 (2015)
BACKGROUND:Obesity has been associated with elevated plasma anandamide levels. In addition, anandamide has been shown to stimulate insulin secretion in vitro, suggesting that anandamide might be linked to hyperinsulinemia. OBJECTIVE:To determine whet
Externí odkaz:
https://doaj.org/article/a9550449b61140ec87d3e78492fae4f0
Autor:
Darko Stefanovski, Joyce M Richey, Orison Woolcott, Maya Lottati, Dan Zheng, Lisa N Harrison, Viorica Ionut, Stella P Kim, Isabel Hsu, Richard N Bergman
Publikováno v:
PLoS ONE, Vol 6, Iss 3, p e18134 (2011)
ObjectiveInsulin resistance induces hyperinsulinemic compensation, which in turn maintains almost a constant disposition index. However, the signal that gives rise to the hyperinsulinemic compensation for insulin resistance remains unknown.MethodsIn
Externí odkaz:
https://doaj.org/article/af10d06985ef4017b754aa68995fdbb7
Autor:
R. Renee Reams, Folakemi T. Odedina, John D. Carpten, Kinfe Redda, Mariana C. Stern, Janice L. Krieger, Jose Aparicio, Brooke Hensel, Nissa Askins, Andre Abreu, Angela Adams, Edward Agyare, Jamel Ali, John M. Allen, Richard Aló, Lourdes Baezconde-Garbanati, Jason Brant, Clyde P. Brown, Sarah G. Buxbaum, Pinchas Cohen, Wendy Cozen, Miriam O. Ezenwa, Sara Falzarano, Roger B. Fillingim, Hernan Flores-Rozas, Kristianna M. Fredenburg, Thomas George, Bo Han, Yong Huang, Chanita Hughes Halbert, Gebre-Egziabher Kiros, Nazarius S. Lamango, Ji-Hyun Lee, Debra E. Lyon, Duane A. Mitchell, Bereket Mochona, Jorge J. Nieva, Ite A. Offringa, Paul Okunieff, Alexander Parker, Suhn K. Rhie, Joyce M. Richey, Sherise C. Rogers, Bodour Salhia, Thomas D. Schmittgen, Richard Segal, Veronica W. Setiawan, Ukamaka Smith, Li-Ming Su, Sandra Suther, Jose Trevino, Enrique I. Velazquez-Villarreal, Fern J. Webb, Anna H. Wu, Yingwei Yao, Diana J. Wilkie
Publikováno v:
Cancer Control, Vol 30 (2023)
Introduction The Florida-California Cancer Research, Education, and Engagement (CaRE 2 ) Health Equity Center is a triad partnership committed to increasing institutional capacity for cancer disparity research, the diversity of the cancer workforce,
Externí odkaz:
https://doaj.org/article/e983d5aca8ef44e3bcc7ae504f4e6bca
Publikováno v:
J Cancer Educ
Using document review, we identified 963 publicly accessible NIH RePORT publications across the 16 funded U54 Partnerships to Advance Cancer Health Equity (PACHE) center programs. Using the 868 publications that met criteria, we determined the freque
Autor:
Deborah J. Clegg, Malini S. Iyer, Joyce M. Richey, Richard N. Bergman, Cathryn M. Kolka, Rebecca L. Paszkiewicz, Orison O. Woolcott, Morvarid Kabir, Stella P. Kim, Darko Stefanovski, Qiang Wu, Isaac Asare-Bediako
Publikováno v:
Am J Physiol Endocrinol Metab
CB1 receptor (CB1R) antagonism improves the deleterious effects of a high-fat diet (HFD) by reducing body fat mass and adipocyte cell size. Previous studies demonstrated that the beneficial effects of the CB1R antagonist rimonabant (RIM) in white adi
Publikováno v:
Molecular nutritionfood research. 63(24)
Scope High sodium and low potassium (HNaLK) intake increases the risk of cardiovascular disease (CVD) and metabolic syndrome. The authors investigate if the dietary minerals interact with the gut microbiota to alter circulating lipid profiles, implic
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:PO-065
What is known about the impact of PACHE can be assessed through varied evaluative methods. Describing the scope of center publications offers one type of insight. Using document review, 963 publicly accessible NIH RePORT publications across the 16 fu
Autor:
Terrell Brown, Anthony J Barrios, Kristi Holmes, SJ Dodd, Lecarde Webb, Nelson Aguila, Leo Spychala, Karen Hubbard, Sarah V. Suiter, Desiree Rivers, Abigail Shain, Helena Loest, Hali R. Robinett, Kelly Laurila, Hala Madanat, Sylvia Peral, Jessica McIntyre, Isabel C. Scarinci, Marilyn Drennan, Melissa Marzan, Joyce M. Richey, Linda S. Behar-Horenstein, Sherri De Jesus
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:D041-D041
Introduction: Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) aim to create stable and long-term partnerships between minority serving institutions and NCI designated Cancer Centers. All CPACHEs are expected to achieve the followi
Autor:
Richard N. Bergman, Morvarid Kabir, Deborah J. Clegg, Orison O. Woolcott, Cathryn M. Kolka, Malini S. Iyer, Joyce M. Richey, Rebecca L. Paszkiewicz
Publikováno v:
Diabetes. 67
We have previously demonstrated that 16 weeks following exposure to a high fat diet (HFD), dogs treated with the CB1-receptor antagonist (Rimonabant (RIM)) upregulated β3-adrenergic receptors, PGC1α, Prdm16, and slight increase of UCP1 in the subcu